Logo image
Pediatric Selective IgM Immunodeficiency
Journal article   Open access

Pediatric Selective IgM Immunodeficiency

Marc F. Goldstein, Alex L. Goldstein, Eliot H. Dunsky, Donald J. Dvorin, George A. Belecanech and Kfir Shamir
Clinical & developmental immunology, v 2008, pp 624850-10
01 Jan 2008
PMID: 19043622
url
https://doi.org/10.1155/2008/624850View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Immunology Life Sciences & Biomedicine Science & Technology
Objective. Limited information exists on features of pediatric Selective IgM immunodeficiency (SIgMID). Previously published pediatric cases and 2 new cases are reviewed. Methods. English literature from PubMed and references from relevant articles were reviewed. Previously reported cases and 2 new cases from an allergy/immunology practice were analyzed. Results. Forty-nine reported cases of SIgMID presented with respiratory infections (77.6%), gastrointestinal disease (16.3%), skin disease (12.2%), and meningitis (8.2%). Mean serum IgM level was 16.5 +/- 13.8mg/dL. Two patients were identified with SIgMID among 6300 active pediatric patients (0.03%) presenting with asthma, vasomotor rhinitis, and recurrent respiratory infections. In the 51 cases reported, none developed lymphoproliferative disease nor evolved into panhypogammaglobulinemia; four fatalities were reported. Conclusions. The prevalence of SIgMID in our pediatric population was 0.03%. In general, respiratory infections are the common comorbid conditions. Death and autoimmune disease are uncommon complications of pediatric SIgMID. (C) Copyright c 2008 Marc F. Goldstein et al.

Metrics

15 Record Views
40 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Immunology
Logo image